Senior Correspondent, London
Ben's Feed
Oct 9, 2014
Oct 9, 2014

Scientists find lung cancer can lie hidden for 20 years

LONDON (Reuters) – Lung cancer can lie dormant for more than 20 years before turning deadly, helping explain why a disease that kills more than 1.5 million a year worldwide is so persistent and difficult to treat, scientists said on Thursday.

Two papers detailing the evolution of lung cancer reveal how after an initial disease-causing genetic fault — often due to smoking — tumor cells quietly develop numerous new mutations, making different parts of the same tumor genetically unique.

Oct 8, 2014
Oct 8, 2014
Oct 8, 2014
Oct 8, 2014

Nobel Prize for seeing how life works at molecular level

STOCKHOLM/LONDON (Reuters) – A German and two American scientists won the 2014 Nobel Prize for Chemistry on Wednesday for smashing the size barrier in optical microscopes, allowing researchers to see individual molecules inside living cells.

U.S. citizens Eric Betzig and William Moerner and Germany’s Stefan Hell won the prize for using fluorescence to take microscopes to a new level, making it possible to study things like the creation of synapses between brain cells in real time.

Oct 8, 2014
Oct 8, 2014
Oct 7, 2014

UK cost agency rejects British company GW’s cannabis drug

LONDON, Oct 8 (Reuters) – A pioneering cannabis drug
developed by British firm GW Pharmaceuticals for
treating spasticity in multiple sclerosis has been rejected as
not cost-effective in the company’s home market.

The National Institute for Health and Care Excellence
(NICE), which determines if medicines are worth using on
England’s state health service, said on Wednesday the modest
benefits and high cost of Sativex did not justify its use.

Oct 7, 2014

Drugmaker GSK investigating corruption allegations in UAE

LONDON (Reuters) – Drugmaker GlaxoSmithKline, which was slapped with a record $489 million (304.26 million pound) fine for corruption in China last month, said on Tuesday it was looking into allegations of corruption in the United Arab Emirates.

Britain’s biggest pharmaceuticals group confirmed the investigation following allegations of improper payments set out in a whistleblower’s email sent to its top management on Monday. The email, purporting to be from a GSK sales manager in the Gulf state, was seen by Reuters.

    • About Ben

      "Ben Hirschler is European pharmaceuticals, biotechnology and healthcare correspondent, based in London. Previously, he was in charge of British company news and before that was posted to Johannesburg, covering the economic challenges facing post-apartheid South Africa."
    • More from Ben

    • Follow Ben